ONLINE DATABASE SEARCH - HIV-LS-368--MEMO
1. 60171 HIV-LS-368; PUBMED-HIV-2/20/2007
Target Recognition by Catechols and beta-Ketoenols: Potential Contribution of Hydrogen Bonding and Mn/Mg Chelation to HIV-1 Integrase Inhibition
Tchertanov, L and Mouscadet, JF
J Med Chem 2007.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17302399&dopt=abstract
2. 60172 HIV-LS-368; PUBMED-HIV-2/20/2007
Evaluation of the HIV-1 reverse transcriptase inhibitory properties of extracts from some medicinal plants in Kenya
Rukunga, GM, Kofi-Tsekpo, MW, Kurokawa, M, Kageyama, S, Mungai, GM, Muli, JM, Tolo, FM, Kibaya, RM, Muthaura, CN, Kanyara, JN, Tukei, PM, and Shiraki, K
Afr J Health Sci 2002. 9(1-2): 81-90
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17298148&dopt=abstract
3. 60173 HIV-LS-368; PUBMED-HIV-2/20/2007
Newly Synthesized APOBEC3G Is Incorporated into HIV Virions, Inhibited by HIV RNA, and Subsequently Activated by RNase H
Soros, VB, Yonemoto, W, and Greene, WC
PLoS Pathog 2007. 3(2): e15
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17291161&dopt=abstract
4. 60174 HIV-LS-368; PUBMED-HIV-2/20/2007
Characterization of novel nonnucleoside reverse transcriptase (RT) inhibitor resistance mutations at residues 132 and 135 in the 51kDa subunit of HIV-1 RT
Nissley, DV, Radzio, J, Ambrose, Z, Sheen, CW, Hamamouch, N, Moore, KL, Tachedjian, G, and Sluis-Cremer, N
Biochem J 2007.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17286555&dopt=abstract
5. 60175 HIV-LS-368; EMBASE-HIV-2/20/2007
Spirodiketopiperazine-based CCR5 antagonists: Lead optimization from biologically active metabolite
Nishizawa, Rena, Nishiyama, Toshihiko, Hisaichi, Katsuya, Matsunaga, Naoki, Minamoto, Chiaki, Habashita, Hiromu, Takaoka, Yoshikazu, Toda, Masaaki, Shibayama, Shiro, Tada, Hideaki, Sagawa, Kenji, Fukushima, Daikichi, Maeda, Kenji, and Mitsuya, Hiroaki
Bioorganic & Medicinal Chemistry Letters 2007. 17(3): 727-731
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TF9-4M7YK0D-2/2/a9e216a52cb272d18c810ebf7f223afb
6. 60176 HIV-LS-368; EMBASE-HIV-2/20/2007
Regioselective synthesis and anti-HIV activity of the novel 2- and 4-substituted pyrazolo[4,5-e][1,2,4]thiadiazines
Liu, Xin Yong, Yan, Ren Zhang, Chen, Nian Gen, and Xu, Wen Fang
Chinese Chemical Letters 2007. 18(2): 137-140
HYPERLINK:
http://www.sciencedirect.com/science/article/B8G3X-4MWJ6HC-8/2/22853ef25d75f4bff7aff6b27515791f
7. 60177 HIV-LS-368; PUBMED-HIV-2/20/2007
Synthesis and biological evaluation of two glycerolipidic prodrugs of didanosine for direct lymphatic delivery against HIV
Lalanne, M, Paci, A, Andrieux, K, Dereuddre-Bosquet, N, Clayette, P, Deroussent, A, Re, M, Vassal, G, Couvreur, P, and Desmaele, D
Bioorg Med Chem Lett 2007.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17276686&dopt=abstract
8. 60178 HIV-LS-368; PUBMED-HIV-2/20/2007
Discovery of small-molecule HIV-1 fusion and integrase inhibitors oleuropein and hydroxytyrosol: Part I. Integrase inhibition
Lee-Huang, S, Huang, PL, Zhang, D, Lee, JW, Bao, J, Sun, Y, Chang, YT, Zhang, J, and Huang, PL
Biochem Biophys Res Commun 2007. 354(4): 872-8
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17275783&dopt=abstract
9. 60179 HIV-LS-368; PUBMED-HIV-2/20/2007
Discovery of Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase Competing with the Nucleotide Substrate
Maga, G, Radi, M, Zanoli, S, Manetti, F, Cancio, R, Hubscher, U, Spadari, S, Falciani, C, Terrazas, M, Vilarrasa, J, and Botta, M
Angew Chem Int Ed Engl 2007.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17274083&dopt=abstract
10. 60180 HIV-LS-368; PUBMED-HIV-2/20/2007
Design of second generation HIV-1 integrase inhibitors
Deng, J, Dayam, R, Al-Mawsawi, LQ, and Neamati, N
Curr Pharm Des 2007. 13(2): 129-41
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17269923&dopt=abstract
11. 60181 HIV-LS-368; EMBASE-HIV-2/20/2007
Quantitative structure-activity relationship studies of HIV-1 integrase inhibition. 1. GETAWAY descriptors
Saiz-Urra, Liane, Gonzalez, Maykel Perez, Fall, Yagamare, and Gomez, Generosa
European Journal of Medicinal Chemistry 2007. 42(1): 64-70
HYPERLINK:
http://www.sciencedirect.com/science/article/B6VKY-4M2WNT6-1/2/e471bb0973750f95408d6ab3a743ede4
12. 60182 HIV-LS-368; PUBMED-HIV-2/20/2007
Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase
Oz, Gleenberg I, Herschhorn, A, Goldgur, Y, and Hizi, A
Arch Biochem Biophys 2007. 458(2): 202-12
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17257575&dopt=abstract
13. 60183 HIV-LS-368; PUBMED-HIV-2/20/2007
Novel resistance mechanism of HIV-1 To peptide fusion inhibitors
Gupta, N, Vassell, R, Wang, W, He, Y, and Weiss, CD
Retrovirology 2006. 3 Suppl 1: S86
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17254216&dopt=abstract
14. 60184 HIV-LS-368; PUBMED-HIV-2/20/2007
Antiretroviral activity of aminothiols, WR2721 and WR1065
Poirier, MC, Shearer, GM, Hardy, AW, Olivero, OA, Walker, DM, and Walker, VE
Retrovirology 2006. 3 Suppl 1: P78
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17254118&dopt=abstract
15. 60185 HIV-LS-368; PUBMED-HIV-2/20/2007
Impact of V2 mutations for escape from a potent neutralizing anti-V3 monoclonal antibody during in vitro selection of a primary HIV-1 isolate
Shibata, J, Yoshimura, K, Honda, A, Koito, A, Murakami, T, and Matsushita, S
J Virol 2007.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17251298&dopt=abstract
16. 60186 HIV-LS-368; PUBMED-HIV-2/20/2007
Novel HIV integrase inhibitors with anti-HIV activity: insights into integrase inhibition from docking studies
Cox, AG and Nair, V
Antivir Chem Chemother 2006. 17(6): 343-53
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17249248&dopt=abstract
17. 60187 HIV-LS-368; PUBMED-HIV-2/20/2007
The benzamide derivative N-[1-(7-tert-Butyl-1H-indol-3-ylmethyl)-2-(4-cyclopropanecarbonyl-3-methyl -piperazin-1-yl)-2-oxo-ethyl]-4-nitro-benzamide (SP-10) reduces HIV-1 infectivity in vitro by modifying actin dynamics
Xu, J, Lecanu, L, Tan, M, Yao, W, Greeson, J, and Papadopoulos, V
Antivir Chem Chemother 2006. 17(6): 331-42
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17249247&dopt=abstract
18. 60188 HIV-LS-368; EMBASE-HIV-2/20/2007
Synthesis of a series of novel 2',3'-dideoxy-6',6'-difluoro-3'-thionucleosides
Yue, Xuyi, Wu, Yun-Yun, and Qing, Feng-Ling
Tetrahedron 2007. 63(7): 1560-1567
HYPERLINK:
http://www.sciencedirect.com/science/article/B6THR-4MNHXY0-4/2/38067b0ac78b738f030a4edebddcb5b2
19. 60189 HIV-LS-368; EMBASE-HIV-2/20/2007
Synthesis and Anti-HIV Studies of 2-Adamantyl-Substituted Thiazolidin-4-ones
Balzarini, Jan, Orzeszko, Barbara, Maurin, Jan K, and Orzeszko, Andrzej
European Journal of Medicinal Chemistry 2007. In Press, Accepted Manuscript: 1199
HYPERLINK:
http://www.sciencedirect.com/science/article/B6VKY-4MVVSJF-3/2/89853149879474d616aa88691126c2af
20. 60190 HIV-LS-368; WOS-HIV-2/12/2007
Retinoic acid inhibits HIV-1-induced podocyte proliferation through the cAMP pathway
He, JCJ, Lu, TC, Fleet, M, Sunamoto, M, Husain, M, Fang, W, Neves, S, Chen, Y, Shankland, S, Iyengar, R, and Klotman, PE
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2007. 18(1): 93-102, 10
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243537800013
21. 60191 HIV-LS-368; WOS-HIV-2/12/2007
Structure-activity relationships of cyclic peptide-based chemokine receptor CXCR4 antagonists: Disclosing the importance of side-chain and backbone functionalities
Ueda, S, Oishi, S, Wang, ZX, Araki, T, Tamamura, H, Cluzeau, J, Ohno, H, Kusano, S, Nakashima, H, Trent, JO, Peiper, SC, and Fujii, N
JOURNAL OF MEDICINAL CHEMISTRY 2007. 50(2): 192-198, 7
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243535600004
22. 60192 HIV-LS-368; WOS-HIV-2/12/2007
Quinoline antimalarials as investigational drugs for HIV-1/AIDS: In vitro effects on HIV-1 replication, HIV-1 response to antiretroviral drugs, and intracellular antiretroviral drug concentrations
Savarino, A, Lucia, MB, ter Heine, R, Rastrelli, E, Rutella, S, Majori, G, Huitema, A, Boelaert, JR, and Cauda, R
DRUG DEVELOPMENT RESEARCH 2006. 67(10): 806-817, 12
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243490000005
23. 60193 HIV-LS-368; WOS-HIV-2/12/2007
Structure-guided peptidomimetic design leads to nanomolar beta-hairpin inhibitors of the Tat-TAR interaction of bovine immunodeficiency Virus
Athanassiou, Z, Patora, K, Dias, RLA, Moehle, K, Robinson, JA, and Varani, G
BIOCHEMISTRY 2007. 46(3): 741-751, 11
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243483100012
24. 60194 HIV-LS-368; WOS-HIV-2/12/2007
Potent knock down of HIV-1 replication by targeting HIV-1 Tat/Rev RNA sequences synergistically with catalytic RNA and DNA
Sood, V, Unwalla, H, Gupta, N, Chakraborti, S, and Banerjea, AC
AIDS 2007. 21 (1): 31-40, 10
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243418900004
25. 60195 HIV-LS-368; WOS-HIV-2/18/2007
Synthesis, anti-HIV, and antifungal activity of new benzensulfonamides bearing the 2,5-disubstituted-1,3,4-oxadiazole moiety
Zareef, M, Iqbal, R, Al-Masoudi, NA, Zaidi, JH, Arfan, M, and Shahzad, SA
PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS 2007. 182(2): 281-298, 18
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243672900005
26. 60196 HIV-LS-368; WOS-HIV-2/18/2007
Fragment based approach for the investigation of HIV-1 integrase inhibition
Polanskia, J, Niedbala, H, Musiola, R, Podeszwa, B, Tabak, D, Palka, A, Mencel, A, Mouscadet, JF, and Le Bret, M
LETTERS IN DRUG DESIGN & DISCOVERY 2007. 4(2): 99-105, 7
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243855800004
27. 60197 HIV-LS-368; WOS-HIV-2/18/2007
The promise of CCR5 antagonists as new therapies for HIV-1
Repik, A, Richards, KH, and Clapham, PR
CURRENT OPINION IN INVESTIGATIONAL DRUGS 2007. 8(2): 130-139, 10
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243838800005
28. 60198 HIV-LS-368; WOS-HIV-2/18/2007
CCR5 receptor antagonists: Discovery and SAR study of guanylhydrazone derivatives
Wei, RG, Arnaiz, DO, Chou, YL, Davey, D, Dunning, L, Lee, W, Lu, SF, Onuffer, J, Ye, B, and Phillips, G
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 2007. 17(1): 231-234, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243630500045